HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial aims to reduce harsh side effects of cancer radiation
Disease control Not yet recruitingThis study is testing a more personalized approach to radiation therapy given after surgery for head and neck cancer. The goal is to see if doctors can safely target radiation to smaller, specific areas to reduce common and severe side effects, without increasing the risk of the …
Matched conditions: HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Olgun Elicin • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New treatment aims to spare patients from Voice-Box removal surgery
Disease control Not yet recruitingThis trial is testing a combination of chemotherapy and immunotherapy drugs (carboplatin/cisplatin, paclitaxel, and toripalimab) for adults with advanced throat cancer. The main goal is to see if this treatment can effectively control the cancer while allowing patients to keep th…
Matched conditions: HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC